Better use of bone scans in prostate cancer

被引：2

作者：

Larson, Steven M. ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Mol Imaging & Therapy Serv, New York, NY 10065 USA

来源：

NATURE REVIEWS UROLOGY | 2015年 / 12卷 / 04期

关键词：

MANAGEMENT;

D O I：

10.1038/nrurol.2014.305

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Bone scanning for radiographical staging of prostate cancer is common; however, its current use in clinical practice is not in line with the published guidelines. A recent study comparing the performance of current practice with that of guideline recommendations found that following the American Urological Association guidelines consistently for newly diagnosed patients with prostate cancer would result in better outcomes.

引用

页码：190 / 191

页数：2

共 50 条

[31] Complementary and alternative medicine use among newly diagnosed prostate cancer patients
McDermott, Cara L.
Blough, David K.
Fedorenko, Catherine R.
Arora, Neeraj K.
Zeliadt, Steven B.
Fairweather, Megan E.
Oakley-Girvan, Ingrid
Van den Eeden, Stephen K.
Ramsey, Scott D.
SUPPORTIVE CARE IN CANCER, 2012, 20 (01) : 65 - 73
[32] What is the appropriate use of palliative docetaxel in castration-resistant prostate cancer?
Steineck, Gunnar
Glimelius, Bengt
ACTA ONCOLOGICA, 2013, 52 (08) : 1589 - 1592
[33] Prostate cancer
Alonso Castillejos-Molina, Ricardo
Bernardo Gabilondo-Navarro, Fernando
SALUD PUBLICA DE MEXICO, 2016, 58 (02): : 279 - 284
[34] Better preservation of erectile function in localized prostate cancer patients with modern proton therapy: Is it cost-effective?
Li, Guo
Xia, Yun-Fei
Huang, Yi-Xiang
Okat, Deniz
Qiu, Bo
Doyen, Jerome
Bondiau, Pierre-Yves
Benezery, Karen
Gao, Jin
Qian, Chao-Nan
PROSTATE, 2022, 82 (15) : 1438 - 1446
[35] Stricter Active Surveillance Criteria for Prostate Cancer do Not Result in Significantly Better Outcomes: A Comparison of Contemporary Protocols
Komisarenko, Maria
Timilshina, Narhari
Richard, Patrick O.
Alibhai, Shabbir M. H.
Hamilton, Robert
Kulkarni, Girish
Zlotta, Alexandre
Fleshner, Neil
Finelli, Antonio
JOURNAL OF UROLOGY, 2016, 196 (06) : 1645 - 1650
[36] Cost-effectiveness of denosumab as a bone protective agent for patients with castration resistant prostate cancer
Dellis, Athanasios
Papatsoris, Athanasios
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2016, 16 (01) : 5 - 10
[37] Advances in Prevention and Treatment of Bone Metastases in Prostate Cancer. Role of RANK/RANKL Inhibition
Gomez-Veiga, F.
Ponce-Reixa, J.
Martinez-Breijo, S.
Planas, J.
Morote, J.
ACTAS UROLOGICAS ESPANOLAS, 2013, 37 (05): : 292 - 304
[38] Testing radical prostatectomy in men with prostate cancer and oligometastases to the bone: a randomized controlled feasibility trial
Sooriakumaran, Prasanna
BJU INTERNATIONAL, 2017, 120 (5B) : E8 - E20
[39] Bone health and its correlates in Korean prostate cancer patients receiving androgen deprivation therapy
Kim, Soo Hyun
Seong, Do Hwan
Yoon, Sang Min
Choi, Young Deuk
Song, Youngkyu
Song, Hosook
Choi, Eunju
EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2016, 21 : 197 - 204
[40] The Low Utility of Pretherapy Scans in Thyroid Cancer Patients
Schlumberger, Martin J.
Pacini, Furio
THYROID, 2009, 19 (08) : 815 - 816

← 1 2 3 4 5 →